APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epigenome Analysis Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Epigenome Analysis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 May 2026198 pages

Choose your research edition.

Industry ResearchEpigenome Analysis Services Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Epigenome Analysis Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Epigenome Analysis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epigenome Analysis Services Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Epigenome Analysis Services Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Epigenome Analysis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Epigenome Analysis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Epigenome Analysis Services include Cellcentric, Syndax, Illumina, Merck, QIAGEN, F. Hoffmann-La Roche, Eisai, Abcam and Diagenode, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Epigenome Analysis Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epigenome Analysis Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epigenome Analysis Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Epigenome Analysis Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Epigenome Analysis Services Segment by Company

Cellcentric

Syndax

Illumina

Merck

QIAGEN

F. Hoffmann-La Roche

Eisai

Abcam

Diagenode

Active Motif

Zymo Research Corporation

Thermo Fisher Scientific

Enzo Life Sciences

EpiGentek Group

New England Biolabs

Epizyme

Domainex

Agilent Technologies

AsisChem

Epigenome Analysis Services Segment by Type

DNA Methylation Analysis

Analysis of DNA Interactions

Chromatin Accessibility

Conformation Assays

Epigenome Analysis Services Segment by Application

Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Others

Epigenome Analysis Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenome Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenome Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenome Analysis Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Epigenome Analysis Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Epigenome Analysis Services industry.

Chapter 3: Detailed analysis of Epigenome Analysis Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenome Analysis Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Epigenome Analysis Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of DNA Methylation Analysis Table 3. Key Players of Analysis of DNA Interactions Table 4. Key Players of Chromatin Accessibility Table 3. Key Players of Conformation Assays Table 4. Global Epigenome Analysis Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Research Institutes Table 6. Key Players of Pharmaceutical Companies Table 7. Key Players of Biotechnology Companies Table 8. Key Players of Others Table 9. Global Epigenome Analysis Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Epigenome Analysis Services Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Epigenome Analysis Services Market Share by Region (2021-2026) Table 12. Global Epigenome Analysis Services Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Epigenome Analysis Services Market Share by Region (2027-2032) Table 14. Epigenome Analysis Services Industry Trends Table 15. Epigenome Analysis Services Industry Drivers Table 16. Epigenome Analysis Services Industry Opportunities and Challenges Table 17. Epigenome Analysis Services Industry Restraints Table 18. Global Epigenome Analysis Services Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Epigenome Analysis Services Revenue Market Share by Company (2021-2026) Table 20. Global Epigenome Analysis Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Epigenome Analysis Services Key Company Head Office and Area Served Table 22. Global Epigenome Analysis Services Company, Product Type & Application Table 23. Global Epigenome Analysis Services Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Epigenome Analysis Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Epigenome Analysis Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Epigenome Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Epigenome Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Epigenome Analysis Services Revenue Market Share by Type (2021-2026) Table 30. Global Epigenome Analysis Services Revenue Market Share by Type (2027-2032) Table 31. Global Epigenome Analysis Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Epigenome Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Epigenome Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Epigenome Analysis Services Revenue Market Share by Application (2021-2026) Table 35. Global Epigenome Analysis Services Revenue Market Share by Application (2027-2032) Table 36. Cellcentric Company Information Table 37. Cellcentric Business Overview Table 38. Cellcentric Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Cellcentric Epigenome Analysis Services Product Portfolio Table 40. Cellcentric Recent Development Table 41. Syndax Company Information Table 42. Syndax Business Overview Table 43. Syndax Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Syndax Epigenome Analysis Services Product Portfolio Table 45. Syndax Recent Development Table 46. Illumina Company Information Table 47. Illumina Business Overview Table 48. Illumina Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Illumina Epigenome Analysis Services Product Portfolio Table 50. Illumina Recent Development Table 51. Merck Company Information Table 52. Merck Business Overview Table 53. Merck Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Merck Epigenome Analysis Services Product Portfolio Table 55. Merck Recent Development Table 56. QIAGEN Company Information Table 57. QIAGEN Business Overview Table 58. QIAGEN Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. QIAGEN Epigenome Analysis Services Product Portfolio Table 60. QIAGEN Recent Development Table 61. F. Hoffmann-La Roche Company Information Table 62. F. Hoffmann-La Roche Business Overview Table 63. F. Hoffmann-La Roche Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. F. Hoffmann-La Roche Epigenome Analysis Services Product Portfolio Table 65. F. Hoffmann-La Roche Recent Development Table 66. Eisai Company Information Table 67. Eisai Business Overview Table 68. Eisai Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Eisai Epigenome Analysis Services Product Portfolio Table 70. Eisai Recent Development Table 71. Abcam Company Information Table 72. Abcam Business Overview Table 73. Abcam Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Abcam Epigenome Analysis Services Product Portfolio Table 75. Abcam Recent Development Table 76. Diagenode Company Information Table 77. Diagenode Business Overview Table 78. Diagenode Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Diagenode Epigenome Analysis Services Product Portfolio Table 80. Diagenode Recent Development Table 81. Active Motif Company Information Table 82. Active Motif Business Overview Table 83. Active Motif Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Active Motif Epigenome Analysis Services Product Portfolio Table 85. Active Motif Recent Development Table 86. Zymo Research Corporation Company Information Table 87. Zymo Research Corporation Business Overview Table 88. Zymo Research Corporation Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Zymo Research Corporation Epigenome Analysis Services Product Portfolio Table 90. Zymo Research Corporation Recent Development Table 91. Thermo Fisher Scientific Company Information Table 92. Thermo Fisher Scientific Business Overview Table 93. Thermo Fisher Scientific Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Thermo Fisher Scientific Epigenome Analysis Services Product Portfolio Table 95. Thermo Fisher Scientific Recent Development Table 96. Enzo Life Sciences Company Information Table 97. Enzo Life Sciences Business Overview Table 98. Enzo Life Sciences Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Enzo Life Sciences Epigenome Analysis Services Product Portfolio Table 100. Enzo Life Sciences Recent Development Table 101. EpiGentek Group Company Information Table 102. EpiGentek Group Business Overview Table 103. EpiGentek Group Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. EpiGentek Group Epigenome Analysis Services Product Portfolio Table 105. EpiGentek Group Recent Development Table 106. New England Biolabs Company Information Table 107. New England Biolabs Business Overview Table 108. New England Biolabs Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. New England Biolabs Epigenome Analysis Services Product Portfolio Table 110. New England Biolabs Recent Development Table 111. Epizyme Company Information Table 112. Epizyme Business Overview Table 113. Epizyme Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Epizyme Epigenome Analysis Services Product Portfolio Table 115. Epizyme Recent Development Table 116. Domainex Company Information Table 117. Domainex Business Overview Table 118. Domainex Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Domainex Epigenome Analysis Services Product Portfolio Table 120. Domainex Recent Development Table 121. Agilent Technologies Company Information Table 122. Agilent Technologies Business Overview Table 123. Agilent Technologies Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Agilent Technologies Epigenome Analysis Services Product Portfolio Table 125. Agilent Technologies Recent Development Table 126. AsisChem Company Information Table 127. AsisChem Business Overview Table 128. AsisChem Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. AsisChem Epigenome Analysis Services Product Portfolio Table 130. AsisChem Recent Development Table 131. North America Epigenome Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 132. North America Epigenome Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 133. North America Epigenome Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 134. North America Epigenome Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 135. North America Epigenome Analysis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Epigenome Analysis Services Market Size by Country (2021-2026) Table 137. North America Epigenome Analysis Services Market Size by Country (2027-2032) Table 138. Europe Epigenome Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 139. Europe Epigenome Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 140. Europe Epigenome Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 141. Europe Epigenome Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 142. Europe Epigenome Analysis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Epigenome Analysis Services Market Size by Country (2021-2026) Table 144. Europe Epigenome Analysis Services Market Size by Country (2027-2032) Table 145. China Epigenome Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 146. China Epigenome Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 147. China Epigenome Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 148. China Epigenome Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 149. Asia Epigenome Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 150. Asia Epigenome Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 151. Asia Epigenome Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 152. Asia Epigenome Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia Epigenome Analysis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Epigenome Analysis Services Market Size by Country (2021-2026) Table 155. Asia Epigenome Analysis Services Market Size by Country (2027-2032) Table 156. South America, Middle East & Africa Epigenome Analysis Services Market Size by Type (2021-2026) & (US$ Million) Table 157. South America, Middle East & Africa Epigenome Analysis Services Market Size by Type (2027-2032) & (US$ Million) Table 158. South America, Middle East & Africa Epigenome Analysis Services Market Size by Application (2021-2026) & (US$ Million) Table 159. South America, Middle East & Africa Epigenome Analysis Services Market Size by Application (2027-2032) & (US$ Million) Table 160. South America, Middle East & Africa Epigenome Analysis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. South America, Middle East & Africa Epigenome Analysis Services Market Size by Country (2021-2026) Table 162. South America, Middle East & Africa Epigenome Analysis Services Market Size by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Epigenome Analysis Services Product Image Figure 2. Global Epigenome Analysis Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Epigenome Analysis Services Market Share by Type: 2025 VS 2032 Figure 4. DNA Methylation Analysis Image Figure 5. Analysis of DNA Interactions Image Figure 6. Chromatin Accessibility Image Figure 7. Conformation Assays Image Figure 8. Global Epigenome Analysis Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Epigenome Analysis Services Market Share by Application: 2025 VS 2032 Figure 10. Research Institutes Image Figure 11. Pharmaceutical Companies Image Figure 12. Biotechnology Companies Image Figure 13. Others Image Figure 14. Global Epigenome Analysis Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 16. Global Epigenome Analysis Services Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Epigenome Analysis Services Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Epigenome Analysis Services Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Epigenome Analysis Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Epigenome Analysis Services Revenue Market Share by Type (2021-2032) Figure 23. Global Epigenome Analysis Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Epigenome Analysis Services Revenue Market Share by Application (2021-2032) Figure 25. North America Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 26. North America Epigenome Analysis Services Market Share by Type (2021-2032) Figure 27. North America Epigenome Analysis Services Market Share by Application (2021-2032) Figure 28. North America Epigenome Analysis Services Market Share by Country (2021-2032) Figure 29. United States Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 30. Canada Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 33. Europe Epigenome Analysis Services Market Share by Type (2021-2032) Figure 34. Europe Epigenome Analysis Services Market Share by Application (2021-2032) Figure 35. Europe Epigenome Analysis Services Market Share by Country (2021-2032) Figure 36. Germany Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 37. France Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 39. Italy Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 40. Russia Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 42. China Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 43. China Epigenome Analysis Services Market Share by Type (2021-2032) Figure 44. China Epigenome Analysis Services Market Share by Application (2021-2032) Figure 45. Asia Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 46. Asia Epigenome Analysis Services Market Share by Type (2021-2032) Figure 47. Asia Epigenome Analysis Services Market Share by Application (2021-2032) Figure 48. Asia Epigenome Analysis Services Market Share by Country (2021-2032) Figure 49. Japan Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 53. India Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 54. Australia Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Epigenome Analysis Services Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Epigenome Analysis Services Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Epigenome Analysis Services Market Share by Country (2021-2032) Figure 59. Brazil Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 64. UAE Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 66. Chile Epigenome Analysis Services Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation Analysis
  • Analysis of DNA Interactions
  • Chromatin Accessibility
  • Conformation Assays
Applications
  • Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
Companies covered
  • Cellcentric
  • Syndax
  • Illumina
  • Merck
  • QIAGEN
  • F. Hoffmann-La Roche
  • Eisai
  • Abcam
  • Diagenode
  • Active Motif
  • Zymo Research Corporation
  • Thermo Fisher Scientific
  • Enzo Life Sciences
  • EpiGentek Group
  • New England Biolabs
  • Epizyme
  • Domainex
  • Agilent Technologies
  • AsisChem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Epigenome Analysis Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Methylation Analysis
  5. 1.2.3 Analysis of DNA Interactions
  6. 1.2.4 Chromatin Accessibility
  7. 1.2.5 Conformation Assays
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Epigenome Analysis Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Research Institutes
  11. 1.3.3 Pharmaceutical Companies
  12. 1.3.4 Biotechnology Companies
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Epigenome Analysis Services Growth Trends by Region
  16. 1.5.1 Global Epigenome Analysis Services Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Epigenome Analysis Services Market Size by Region (2021-2026)
  18. 1.5.3 Epigenome Analysis Services Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Epigenome Analysis Services Market Dynamics
  1. 2.1 Epigenome Analysis Services Industry Trends
  2. 2.2 Epigenome Analysis Services Industry Drivers
  3. 2.3 Epigenome Analysis Services Industry Opportunities and Challenges
  4. 2.4 Epigenome Analysis Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Epigenome Analysis Services Revenue by Company (2021-2026)
  2. 3.2 Global Epigenome Analysis Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Epigenome Analysis Services Key Company Head office and Area Served
  4. 3.4 Global Epigenome Analysis Services Company, Product Type & Application
  5. 3.5 Global Epigenome Analysis Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Epigenome Analysis Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Epigenome Analysis Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Epigenome Analysis Services Tier 1, Tier 2, and Tier 3
4 Epigenome Analysis Services Market by Type
  1. 4.1 Global Epigenome Analysis Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Epigenome Analysis Services Market Size by Type (2021-2032)
  3. 4.3 Global Epigenome Analysis Services Market Size Share by Type (2021-2032)
5 Epigenome Analysis Services Market by Application
  1. 5.1 Global Epigenome Analysis Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Epigenome Analysis Services Market Size by Application (2021-2032)
  3. 5.3 Global Epigenome Analysis Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Cellcentric
  2. 6.1.1 Cellcentric Company Information
  3. 6.1.2 Cellcentric Business Overview
  4. 6.1.3 Cellcentric Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Cellcentric Epigenome Analysis Services Product Portfolio
  6. 6.1.5 Cellcentric Recent Developments
  7. 6.2 Syndax
  8. 6.2.1 Syndax Company Information
  9. 6.2.2 Syndax Business Overview
  10. 6.2.3 Syndax Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Syndax Epigenome Analysis Services Product Portfolio
  12. 6.2.5 Syndax Recent Developments
  13. 6.3 Illumina
  14. 6.3.1 Illumina Company Information
  15. 6.3.2 Illumina Business Overview
  16. 6.3.3 Illumina Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Illumina Epigenome Analysis Services Product Portfolio
  18. 6.3.5 Illumina Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Merck Epigenome Analysis Services Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 QIAGEN
  26. 6.5.1 QIAGEN Company Information
  27. 6.5.2 QIAGEN Business Overview
  28. 6.5.3 QIAGEN Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 QIAGEN Epigenome Analysis Services Product Portfolio
  30. 6.5.5 QIAGEN Recent Developments
  31. 6.6 F. Hoffmann-La Roche
  32. 6.6.1 F. Hoffmann-La Roche Company Information
  33. 6.6.2 F. Hoffmann-La Roche Business Overview
  34. 6.6.3 F. Hoffmann-La Roche Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 F. Hoffmann-La Roche Epigenome Analysis Services Product Portfolio
  36. 6.6.5 F. Hoffmann-La Roche Recent Developments
  37. 6.7 Eisai
  38. 6.7.1 Eisai Company Information
  39. 6.7.2 Eisai Business Overview
  40. 6.7.3 Eisai Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Eisai Epigenome Analysis Services Product Portfolio
  42. 6.7.5 Eisai Recent Developments
  43. 6.8 Abcam
  44. 6.8.1 Abcam Company Information
  45. 6.8.2 Abcam Business Overview
  46. 6.8.3 Abcam Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Abcam Epigenome Analysis Services Product Portfolio
  48. 6.8.5 Abcam Recent Developments
  49. 6.9 Diagenode
  50. 6.9.1 Diagenode Company Information
  51. 6.9.2 Diagenode Business Overview
  52. 6.9.3 Diagenode Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Diagenode Epigenome Analysis Services Product Portfolio
  54. 6.9.5 Diagenode Recent Developments
  55. 6.10 Active Motif
  56. 6.10.1 Active Motif Company Information
  57. 6.10.2 Active Motif Business Overview
  58. 6.10.3 Active Motif Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Active Motif Epigenome Analysis Services Product Portfolio
  60. 6.10.5 Active Motif Recent Developments
  61. 6.11 Zymo Research Corporation
  62. 6.11.1 Zymo Research Corporation Company Information
  63. 6.11.2 Zymo Research Corporation Business Overview
  64. 6.11.3 Zymo Research Corporation Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Zymo Research Corporation Epigenome Analysis Services Product Portfolio
  66. 6.11.5 Zymo Research Corporation Recent Developments
  67. 6.12 Thermo Fisher Scientific
  68. 6.12.1 Thermo Fisher Scientific Company Information
  69. 6.12.2 Thermo Fisher Scientific Business Overview
  70. 6.12.3 Thermo Fisher Scientific Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Thermo Fisher Scientific Epigenome Analysis Services Product Portfolio
  72. 6.12.5 Thermo Fisher Scientific Recent Developments
  73. 6.13 Enzo Life Sciences
  74. 6.13.1 Enzo Life Sciences Company Information
  75. 6.13.2 Enzo Life Sciences Business Overview
  76. 6.13.3 Enzo Life Sciences Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Enzo Life Sciences Epigenome Analysis Services Product Portfolio
  78. 6.13.5 Enzo Life Sciences Recent Developments
  79. 6.14 EpiGentek Group
  80. 6.14.1 EpiGentek Group Company Information
  81. 6.14.2 EpiGentek Group Business Overview
  82. 6.14.3 EpiGentek Group Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 EpiGentek Group Epigenome Analysis Services Product Portfolio
  84. 6.14.5 EpiGentek Group Recent Developments
  85. 6.15 New England Biolabs
  86. 6.15.1 New England Biolabs Company Information
  87. 6.15.2 New England Biolabs Business Overview
  88. 6.15.3 New England Biolabs Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 New England Biolabs Epigenome Analysis Services Product Portfolio
  90. 6.15.5 New England Biolabs Recent Developments
  91. 6.16 Epizyme
  92. 6.16.1 Epizyme Company Information
  93. 6.16.2 Epizyme Business Overview
  94. 6.16.3 Epizyme Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Epizyme Epigenome Analysis Services Product Portfolio
  96. 6.16.5 Epizyme Recent Developments
  97. 6.17 Domainex
  98. 6.17.1 Domainex Company Information
  99. 6.17.2 Domainex Business Overview
  100. 6.17.3 Domainex Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Domainex Epigenome Analysis Services Product Portfolio
  102. 6.17.5 Domainex Recent Developments
  103. 6.18 Agilent Technologies
  104. 6.18.1 Agilent Technologies Company Information
  105. 6.18.2 Agilent Technologies Business Overview
  106. 6.18.3 Agilent Technologies Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Agilent Technologies Epigenome Analysis Services Product Portfolio
  108. 6.18.5 Agilent Technologies Recent Developments
  109. 6.19 AsisChem
  110. 6.19.1 AsisChem Company Information
  111. 6.19.2 AsisChem Business Overview
  112. 6.19.3 AsisChem Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 AsisChem Epigenome Analysis Services Product Portfolio
  114. 6.19.5 AsisChem Recent Developments
7 North America
  1. 7.1 North America Epigenome Analysis Services Market Size (2021-2032)
  2. 7.2 North America Epigenome Analysis Services Market Size by Type
  3. 7.2.1 North America Epigenome Analysis Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Epigenome Analysis Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Epigenome Analysis Services Market Share by Type (2021-2032)
  6. 7.3 North America Epigenome Analysis Services Market Size by Application
  7. 7.3.1 North America Epigenome Analysis Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Epigenome Analysis Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Epigenome Analysis Services Market Share by Application (2021-2032)
  10. 7.4 North America Epigenome Analysis Services Market Size by Country
  11. 7.4.1 North America Epigenome Analysis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Epigenome Analysis Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Epigenome Analysis Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Epigenome Analysis Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Epigenome Analysis Services Market Size (2021-2032)
  2. 8.2 Europe Epigenome Analysis Services Market Size by Type
  3. 8.2.1 Europe Epigenome Analysis Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Epigenome Analysis Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Epigenome Analysis Services Market Share by Type (2021-2032)
  6. 8.3 Europe Epigenome Analysis Services Market Size by Application
  7. 8.3.1 Europe Epigenome Analysis Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Epigenome Analysis Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Epigenome Analysis Services Market Share by Application (2021-2032)
  10. 8.4 Europe Epigenome Analysis Services Market Size by Country
  11. 8.4.1 Europe Epigenome Analysis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Epigenome Analysis Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Epigenome Analysis Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Epigenome Analysis Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Epigenome Analysis Services Market Size (2021-2032)
  2. 9.2 China Epigenome Analysis Services Market Size by Type
  3. 9.2.1 China Epigenome Analysis Services Market Size by Type (2021-2026)
  4. 9.2.2 China Epigenome Analysis Services Market Size by Type (2027-2032)
  5. 9.2.3 China Epigenome Analysis Services Market Share by Type (2021-2032)
  6. 9.3 China Epigenome Analysis Services Market Size by Application
  7. 9.3.1 China Epigenome Analysis Services Market Size by Application (2021-2026)
  8. 9.3.2 China Epigenome Analysis Services Market Size by Application (2027-2032)
  9. 9.3.3 China Epigenome Analysis Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Epigenome Analysis Services Market Size (2021-2032)
  2. 10.2 Asia Epigenome Analysis Services Market Size by Type
  3. 10.2.1 Asia Epigenome Analysis Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Epigenome Analysis Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Epigenome Analysis Services Market Share by Type (2021-2032)
  6. 10.3 Asia Epigenome Analysis Services Market Size by Application
  7. 10.3.1 Asia Epigenome Analysis Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Epigenome Analysis Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Epigenome Analysis Services Market Share by Application (2021-2032)
  10. 10.4 Asia Epigenome Analysis Services Market Size by Country
  11. 10.4.1 Asia Epigenome Analysis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Epigenome Analysis Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Epigenome Analysis Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Epigenome Analysis Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Epigenome Analysis Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Epigenome Analysis Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Epigenome Analysis Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Epigenome Analysis Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Epigenome Analysis Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Epigenome Analysis Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Epigenome Analysis Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Epigenome Analysis Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Epigenome Analysis Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Epigenome Analysis Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Epigenome Analysis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Epigenome Analysis Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Epigenome Analysis Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Epigenome Analysis Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst